You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

progression

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Outcomes in HR+ and HER2-low/Negative Breast Cancer

Active, not recruiting
  • Hormone-receptor-positive Breast Cancer
  • +2 more
  • No drug
  • Cambridge, Massachusetts
    ConcertAI database
Sep 8, 2023

Breast Cancer, Ovarian Cancer Trial in Germany (Fasting, Vegan)

Active, not recruiting
  • Breast Cancer
  • Ovarian Cancer
  • Fasting
  • Vegan
  • Freiburg im Breisgau, Baden-Württemberg, Germany
  • +7 more
Dec 12, 2022

Metastatic Colorectal Cancer Trial in Beijing (fruquintinib plus capecitabine)

Recruiting
  • Metastatic Colorectal Cancer
  • fruquintinib plus capecitabine
  • Beijing, China
    National Center/Cancer Hospital, China Academy of Medical Scienc
Aug 17, 2022

Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer Trial (CTX-009, Paclitaxel)

Not yet recruiting
  • Biliary Tract Cancer
  • +3 more
  • (no location specified)
Aug 16, 2022

Advanced Melanoma

Enrolling by invitation
  • Melanoma
  • observational
  • Durham, North Carolina
    Duke University Medical Center
Aug 16, 2022

NSCLC Trial in London (MPDL3280A, Vemurafenib, Alectinib)

Recruiting
  • Non-small Cell Lung Cancer
  • London, United Kingdom
    Univeristy College London Hospital
Feb 22, 2022

Anemia, MDS Trial in Germany (Canakinumab Injection)

Recruiting
  • Anemia
  • Myelodysplastic Syndromes
  • Canakinumab Injection
  • Berlin, Germany
  • +5 more
Nov 8, 2022

Prediction of Chronic Allograft Nephropathy

Completed
  • Kidney Transplantation
  • +2 more
  • mRNAs encoding genes
  • Paris, France
    Necker Hospital
Apr 13, 2021

Advanced Non Small Cell Lung Cancer Trial in Worldwide (ATL001, Pembrolizumab)

Recruiting
  • Advanced Non Small Cell Lung Cancer
  • New Haven, Connecticut
  • +16 more
Jan 6, 2023

Scoliosis Trial in Rochester (AVBT using Dynesys System Components, Spine fusion)

Recruiting
  • Scoliosis
  • AVBT using Dynesys System Components
  • Spine fusion
  • Rochester, Minnesota
    Mayo Clinic
Jun 23, 2022

Breast Cancer, Breast Adenocarcinoma, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Bronx (Rebastinib,

Terminated
  • Breast Cancer
  • +4 more
  • Bronx, New York
    Montefiore Medical Center
Mar 23, 2022

Breast Cancer Trial in Detroit (biological, drug, other)

Terminated
Has Results
  • Breast Cancer
  • HER2Bi-armed activated T cells
  • +2 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Nov 29, 2022

Trifluridine/ Tipiracil in Chemorefractory mCRC in Greece

Completed
  • Metastatic Colorectal Cancer
  • Heraklion, Crete, Greece
  • +7 more
Mar 4, 2022

Uterine Carcinosarcoma, Advanced Uterine Carcinosarcoma Trial in United States (Pembrolizumab, Lenvatinib)

Recruiting
  • Uterine Carcinosarcoma
  • Advanced Uterine Carcinosarcoma
  • Basking Ridge, New Jersey
  • +6 more
Apr 27, 2022

Prostate Cancer Recurrent Trial in Lexington (Hydroxychloroquine Sulfate 200Mg Tab)

Recruiting
  • Prostate Cancer Recurrent
  • Hydroxychloroquine Sulfate 200Mg Tab
  • Lexington, Kentucky
    Markey Cancer Center - University of Kentucky
Jul 6, 2021

Hepatocellular Carcinoma Trial (SBRT + atezolizumab and bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • SBRT + atezolizumab and bevacizumab
  • (no location specified)
Aug 3, 2022

Locally Advanced Basal Cell Carcinoma Trial in Brescia (Sonidegib)

Recruiting
  • Locally Advanced Basal Cell Carcinoma
  • Brescia, Italy
    Asst Degli Spedali Civili Di Brescia
Aug 3, 2022

Metastatic Breast Cancer Trial in Chuo-ku, Nihonbashi, Koami-cho (Paclitaxel, Bevacizumab, Letrozole)

Completed
  • Metastatic Breast Cancer
  • Chuo-ku, Nihonbashi, Koami-cho, Tokyo, Japan
    Japan Breast Cancer Research Group
Aug 2, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +2 more
  • Columbus, Ohio
  • +2 more
Aug 10, 2022

24-hour Urinary Electrolyte Excretion in Chronic Kidney Disease

Completed
  • Chronic Kidney Diseases
  • Electrolyte Imbalance
    • (no location specified)
    Sep 19, 2022

    Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Santa Monica (Trabectedin, Ipilimumab, Nivolumab)

    Recruiting
    • Advanced Soft Tissue Sarcoma
    • Metastatic Soft Tissue Sarcoma
    • Santa Monica, California
      Sarcoma Oncology Research Center
    May 4, 2022

    Tumors, Rectal Trial (Dostarlimab)

    Not yet recruiting
    • Neoplasms, Rectal
    • Dostarlimab
    • (no location specified)
    Feb 2, 2023

    Endometrial Serous Adenocarcinoma, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States

    Recruiting
    • Endometrial Serous Adenocarcinoma
    • +2 more
    • Biopsy
    • +3 more
    • Phoenix, Arizona
    • +3 more
    Feb 2, 2023

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,

    Suspended
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +23 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Feb 23, 2022

    Cleveland Heart and Metabolic Prevention Study

    Active, not recruiting
    • Heart Failure Risk Factors in Healthy Individuals
      • Cleveland, Ohio
        Cleveland Clinic
      Sep 28, 2022